Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2026-01-29 @ 3:23 PM
Study NCT ID:
NCT03045120
Status:
COMPLETED
Last Update Posted:
2022-12-21
First Post:
2017-01-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-31
First Submit QC Date:
None
Study First Post Date:
2017-02-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-20
Last Update Post Date:
2022-12-21
Last Update Post Date Type:
ACTUAL